Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Provision for income tax	$ 4	$ 16	$ 8	$ 34
Effective income tax rate	1.00%	(0.80%)	1.00%	(1.10%)

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.